Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TBN tablets for type 2 diabetic kidney disease
ChiCTR2000040820Phase 2Recruiting
- Sponsor
- Beijing Tongren Hospital
- Start
- Nov 2019
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tetramethylpyrazine nitrone in diabetic glomerulosclerosis and type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Beijing Tongren Hospital. Primary endpoint: urinary albumin-to-creatinine ratio. Started Nov 2019; status: recruiting.
02
Drugs
tetramethylpyrazine nitrone
03
Conditions
diabetic glomerulosclerosistype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR2000040820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040820.